18F-FLT PET/CT Adds Value to 18F-FDG PET/CT for Diagnosing Relapse After Definitive Radiotherapy in Patients with Lung Cancer: Results of a Prospective Clinical Trial-Reference-Cited by-同舟云学术

18F-FLT PET/CT Adds Value to 18F-FDG PET/CT for Diagnosing Relapse After Definitive Radiotherapy in Patients with Lung Cancer: Results of a Prospective Clinical Trial

Published:2020-10-09 Issue:5 Volume:62 Page:628-635
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Christensen Tine Nøhr,Langer Seppo W.,Persson Gitte,Larsen Klaus Richter,Loft Annika,Amtoft Annemarie Gjelstrup,Berthelsen Anne Kiil,Johannesen Helle Hjorth,Keller Sune Høgild,Kjaer Andreas,Fischer Barbara Malene

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference20 articles.

1. A systematic literature review on salvage radiotherapy for local or regional recurrence after previous stereotactic body radiotherapy for lung cancer;Matsuo;Technol Cancer Res Treat.,2018

2. Stereotactic body radiation therapy for non-small cell lung cancer: a review;Prezzano;World J Clin Oncol.,2019

3. Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial

4. Differentiation of tumor recurrence from radiation-induced pulmonary fibrosis after stereotactic ablative radiotherapy for lung cancer: characterization of 18F-FDG PET/CT findings

5. Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. [18F]FAPI adds value to [18F]FDG PET/CT for diagnosing lymph node metastases in stage I-IIIA non-small cell lung cancer: a prospective study;Cancer Imaging;2024-06-03

2. Positron Emission Tomography Imaging of Tumor Proliferation and DNA Repair;The Cancer Journal;2024-05

3. 18F-Thymidine;Radiopharmaceuticals;2024

4. Cancer;Transpathology;2024

5. Strahlentherapie;PET/CT-Atlas;2024